DK0858341T3 - Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin - Google Patents

Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin

Info

Publication number
DK0858341T3
DK0858341T3 DK96930553T DK96930553T DK0858341T3 DK 0858341 T3 DK0858341 T3 DK 0858341T3 DK 96930553 T DK96930553 T DK 96930553T DK 96930553 T DK96930553 T DK 96930553T DK 0858341 T3 DK0858341 T3 DK 0858341T3
Authority
DK
Denmark
Prior art keywords
cisplatin
advanced cancer
combination therapy
cancer including
including temozolomide
Prior art date
Application number
DK96930553T
Other languages
Danish (da)
English (en)
Inventor
Margaret H Dugan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0858341T3 publication Critical patent/DK0858341T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96930553T 1995-08-28 1996-08-26 Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin DK0858341T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US287795P 1995-08-28 1995-08-28
US62479596A 1996-03-27 1996-03-27
PCT/US1996/013479 WO1997007804A1 (fr) 1995-08-28 1996-08-26 Therapie d'association pour des cancers avances comprenant le tremozolomide et le cisplatine

Publications (1)

Publication Number Publication Date
DK0858341T3 true DK0858341T3 (da) 2001-11-19

Family

ID=26670993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96930553T DK0858341T3 (da) 1995-08-28 1996-08-26 Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin

Country Status (11)

Country Link
EP (1) EP0858341B1 (fr)
JP (1) JPH10511108A (fr)
AT (1) ATE207359T1 (fr)
AU (1) AU6955396A (fr)
CA (1) CA2229141A1 (fr)
DE (1) DE69616367T2 (fr)
DK (1) DK0858341T3 (fr)
ES (1) ES2162092T3 (fr)
GR (1) GR3037047T3 (fr)
PT (1) PT858341E (fr)
WO (1) WO1997007804A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251850B1 (fr) * 2000-01-26 2006-06-21 Schering Corporation Preparation combinee dans la therapie du cancer
EP2329818A1 (fr) * 2006-01-17 2011-06-08 Abbott Laboratories Polythérapie avec des inhibiteurs PARP
PE20120254A1 (es) 2006-04-05 2012-03-26 Opko Health Inc Formulaciones farmaceuticas de sales de 8-[1-(3,5-bis-(trifluorometil)fenil)-etoximetil]-8-fenil-1,7-diaza-espiro[4,5]decan-2-ona
EP2662373A1 (fr) 2006-04-05 2013-11-13 OPKO Health, Inc. Sels d'hydrochlorure de 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one et leur procédé de préparation
WO2010081823A1 (fr) * 2009-01-13 2010-07-22 Proteosys Ag Pirenzépine au titre d'agent otoprotecteur
WO2021146266A1 (fr) * 2020-01-13 2021-07-22 Memorial Sloan Kettering Cancer Center Méthodes et compositions pour une immunothérapie anticancéreuse

Also Published As

Publication number Publication date
EP0858341A1 (fr) 1998-08-19
EP0858341B1 (fr) 2001-10-24
WO1997007804A1 (fr) 1997-03-06
JPH10511108A (ja) 1998-10-27
DE69616367D1 (de) 2001-11-29
DE69616367T2 (de) 2002-06-27
AU6955396A (en) 1997-03-19
PT858341E (pt) 2002-03-28
CA2229141A1 (fr) 1997-03-06
MX9801585A (es) 1998-05-31
GR3037047T3 (en) 2002-01-31
ES2162092T3 (es) 2001-12-16
ATE207359T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
FI971290A (fi) Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
DE69617469T2 (de) Behandlung von multipler sklerose
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
CY1105564T1 (el) Θεραπεια συνδυασμου για καρκινο
DK0858341T3 (da) Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
IL121440A0 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
DE69218200D1 (de) Behandlung von leberkrebs
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
SU1823193A1 (ru) Способ лечения рака гортани
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
WO2000033823A3 (fr) Procedes d'utilisation de temozolomide dans le traitement de cancers
UA10221A (uk) Спосіб лікування рецидивного бронхіту у дітей
ATE375796T1 (de) Verwendung von devazepide als schmerzmittel
UA28928A (uk) Спосіб лікування гнійно-запальних захворювань м'яких тканин
RU97114158A (ru) Способ лечения злокачественных опухолей
UA30251A (uk) Спосіб лікування гіпертонії сфінктера одді у хворих на хронічний безкам'яний холецистит при поєднанні з підвищенням тонусу симпатичної нервової системи
UA23985A (uk) Спосіб лікуваhhя запальhих захворюваhь вhутрішhіх геhіталій у дівчат та підлітків